Precision Medicine Resource Library

Further your knowledge of precision medicine with our comprehensive collection of whitepapers, e-books, videos, articles, and more.
To browse learning content by precision medicine subtopics, visit the main  Precision Medicine Learning Center home.

Precision Medicine Science Center

The Precision Medicine Science Center (PMSC) partners and collaborates with health and science innovators to accelerate their journey from research to clinic.

Endeavor to Improve Patient Outcomes

Precision oncology using next-generation sequencing accelerates targeted therapy treatment selection and improves patient outcomes. 

Precision Prescribing with Pharmacogenomics

Pharmacogenomics is the study of how genetic variation impacts medication responses. 

Precision Medicine Creating Value for Everyone

Precision medicine is changing the focus from treating disease to maintaining health, and from episodic care to continued vigilance. 

Pharmacogenomics Improves Health System Performance: Economic Benefits and Key Decisions

We have three main solutions for pharmacogenomics—using real-time PCR, microarray, and next-generation sequencing technologies.

Why Community-Based Hospitals Are Bringing Next Generation Sequencing In-House

We have three main solutions for pharmacogenomics—using real-time PCR, microarray, and next-generation sequencing technologies.

Precision Medicine Success Hinges on Widespread Adoption

Groundbreaking advances in precision medicine promise to change how we approach diseases such as cancer, but widespread adoption of precision medicine depends upon establishing clinial utility and forging proven pathways to reimbursement. 

Cancer Patient Finds Hope and Remission in CAR T-Cell Therapy

When the U.S. Food and Drug Administration (FDA) announced its approval of a new immunotherapy in August 2017, it was a breakthrough for precision medicine. Learn more about the story of one of the patients who found hope using CAR T-Cell Therapy.

Pharmacogenomics is Ready to Go Mainstream

The estimated annual cost of drug-related morbidity and mortality resulting from non-optimized medication therapy in 2016 alone was equivalent to 16 percent of the country’s total health care expenditures. Learn how pharmacogenomics promises to change that.